Schmidts "wilderness year"
This article was originally published in Clinica
One year into her tenure as German health minister, Ulla Schmidt is facing a barrage of criticism for her apparent failure to act on promises. Her appointment to the post in January 2001 was seen by many healthcare players as an opportunity for comprehensive reform. Ms Schmidt's ideas on reform, however, lack substance and direction, they now claim.
You may also be interested in...
A collaboration between Novo and Fauna will look at animal hibernation and genetic sequencing for hints toward novel therapies for obesity. Pfizer will use Insilico’s machine learning technology in target validation.
The introduction of gene therapies has been the highest-profile new modality to reach the market, but new RNA-based therapeutics hold significant potential and could be more accessible for patients. Scrip reviews the leading drug developers in this space.